Understanding Myelofibrosis: Molecular Biology, JAK Inhibitors, and Emerging Therapeutics

Co-Chairs Srdan Verstovsek, MD, PhD, and Ruben A. Mesa, MD, FACP, discuss myelofibrosis in this CME activity titled “Understanding the Clinical Spectrum of Myelofibrosis: Expert Perspectives on Molecular Biology, JAK Inhibitors, and Emerging Therapeutics.” For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/ZZW865. CME credit will be available until October 9, 2022.